Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011:5:1-3.
doi: 10.2174/1874104501105010001. Epub 2011 Mar 9.

Drug development to protozoan diseases

Lianet Monzote  1 , Afshan Siddiq
Affiliations

Drug development to protozoan diseases

Lianet Monzote et al. Open Med Chem J. 2011.

Abstract

The diseases caused by protozoan parasite are responsible for considerable mortality and morbidity, affecting more than 500 million of people in the world. The epidemiological control of protozoan is unsatisfactory due to difficulties of vector and reservoir control; while the progress in the development of vaccine tends to be slow and arduous. Currently, the chemotherapy remains essential component of both clinical management and disease control programmer in endemic areas. The drugs in use as anti-protozoan agents were discovered over 50 years and a number of factors limit their utility such as: high cost, poor compliance, drug resistance, low efficacy and poor safety. In the recent years, the searches about the development of new drugs against protozoa parasite have been increased. This special issue of The Open Medicinal Chemistry Journal will present some of developments in this field with the aim to shown the significant advances in the discovery of new anti-protozoan drugs.

Keywords: Anti-infective; anti-protozoan; drugs..

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Fennell BJ, Naughton JA, Barlow J, Brennan G, Fairweather I, Hoey E, McFerran N, Trudgett A, Bell A. Microtubules as antiparasitic drug targets. Expert Opin. Drug Discov. 2008;3:501–518. - PubMed
    1. Pink R, Hudson A, Mouriés MA, Bendig M. Opportunities and challenges in antiparasitic drug discovery. Nat. Rev. Drug Discov. 2005;4:727–740. - PubMed
    1. Tekwani BL, Walker LA. 8-Aminoquinolines: future role as antiprotozoal drugs. Curr. Opin. Infect. Dis. 2006;19:623–631. - PubMed
    1. Watkins BM. Drugs for the control of parasitic diseases: current status and development. Trends Parasitol. 2003;19:477–478. - PubMed
    1. Dupouy-Camet J. New drugs for the treatment of human parasitic protozoa. Parasitologia. 2004;46:81–84. - PubMed

LinkOut - more resources